false
Catalog
Medical Considerations for Patients with Opioid Us ...
Presentation
Presentation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Dr. Jeanette Tetrault, a Professor of Medicine and Public Health at Yale School of Medicine, presents a module on Medical Considerations for Patients with Opioid Use Disorder. She discusses the prevention and treatment of opioid use disorder, as well as the prevention and treatment of substance use disorder. Dr. Tetrault emphasizes the importance of recognizing and treating the infectious complications associated with injection drug use, including skin and soft tissue infections and infective endocarditis. She also discusses the screening and treatment options for hepatitis C (HCV) and HIV in patients with substance use disorder. Dr. Tetrault highlights the effectiveness of addiction treatment as a form of prevention for both HCV and HIV transmission. She also emphasizes the importance of behavioral risk reduction counseling and the availability of antiviral-based interventions, such as pre-exposure prophylaxis (PrEP) for HIV prevention. The video provides references and resources for further information on these topics.
Asset Subtitle
View the recorded presentation to attest that you have viewed the presentation in its entirety.
Keywords
Opioid Use Disorder
Prevention
Treatment
Substance Use Disorder
Infectious Complications
HCV
HIV
Addiction Treatment
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English